- Home
- WF vs HOLX Comparison
WF vs HOLX Comparison
Compare WF & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WF | HOLX |
|---|---|---|
| Founded | 1899 | 1985 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.0B | 16.6B |
| IPO Year | 2003 | 1995 |
Fundamental Metrics
Financial Performance| Metric | WF | HOLX |
|---|---|---|
| Price | $65.60 | $75.60 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $77.89 |
| AVG Volume (30 Days) | 100.3K | ★ 3.1M |
| Earning Date | 04-24-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | ★ $4,100,500,000.00 |
| Revenue This Year | $17.55 | $4.74 |
| Revenue Next Year | $3.99 | $5.03 |
| P/E Ratio | ★ $9.03 | $95.71 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $29.44 | $51.90 |
| 52 Week High | $84.71 | $75.78 |
Technical Indicators
Market Signals| Indicator | WF | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 45.19 | 59.24 |
| Support Level | $64.22 | $75.10 |
| Resistance Level | $68.28 | N/A |
| Average True Range (ATR) | 2.06 | 0.20 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 56.98 | 83.33 |
Price Performance
Historical ComparisonAbout WF Woori Financial Group Inc. (each representing three (3) shares of)
Woori Financial Group Inc is a banking and financial services holding company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. The operating segments of the company include Banking, Credit card, Capital, Investment banking, and others.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.